8-K: Incannex Shareholders Elect Directors, Ratify Auditor

Incannex Healthcare Inc. held its 2025 Annual Meeting of Stockholders, electing two directors and ratifying Grant Thornton Audit Pty Ltd as its independent auditor.

Summary

• The 2025 Annual Meeting of Stockholders for Incannex Healthcare Inc. was held virtually on January 15, 2026, at 11:00 a.m. Gulf Standard Time.
• As of the record date of October 24, 2025, 347,705,507 shares of common stock were issued and outstanding and eligible to vote.
• A quorum was present with 119,550,295 shares, representing approximately 34.38% of the eligible shares.
• Dr. George Anastassov was elected as a director with 55,032,850 votes For, 3,295,276 votes Withheld, and 61,222,169 Broker Non-Votes.
• Robert Clark was elected as a director with 56,220,279 votes For, 2,107,847 votes Withheld, and 61,222,169 Broker Non-Votes.
• Both elected directors will serve until the 2028 Annual Meeting of Stockholders.
• The appointment of Grant Thornton Audit Pty Ltd as the independent registered public accounting firm for the fiscal year ending June 30, 2026, was ratified with 110,346,963 votes For, 7,877,386 votes Against, and 1,325,946 votes Abstained.

Sentiment

Score: 7

Explanation: The filing reports the successful completion of a routine annual meeting, with all proposed matters passing, indicating stable corporate governance. The presence of significant broker non-votes and some votes against the auditor are minor points in an otherwise expected outcome.

Positives

• The Annual Meeting successfully achieved a quorum, allowing for the transaction of business.
• Both nominated directors, Dr. George Anastassov and Robert Clark, were successfully elected to the Board.
• The appointment of Grant Thornton Audit Pty Ltd as the independent auditor was ratified, ensuring continued financial oversight.

Negatives

• A significant number of Broker Non-Votes (61,222,169 for each nominee) were recorded for the director elections, indicating a portion of shares not voted on these proposals.
• There were 7,877,386 votes against the ratification of the independent auditor, representing a notable dissent.

Future Outlook

The filing does not contain specific forward-looking statements or guidance beyond the terms of service for the elected directors and the appointed auditor.

Management Comments

• Joel Latham, Chief Executive Officer and President, signed the report on behalf of Incannex Healthcare Inc.

Industry Context

This announcement reflects routine corporate governance activities for a publicly traded company, ensuring the election of board members and the appointment of an independent auditor, which are standard practices across the industry for maintaining transparency and accountability to shareholders.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: Confirmed board leadership and independent auditor, ensuring governance continuity and oversight of their investment.
• Management: Board composition confirmed, providing strategic direction and accountability.

Next Steps

• The newly elected directors, Dr. George Anastassov and Robert Clark, will serve on the Board until the 2028 Annual Meeting of Stockholders.
• Grant Thornton Audit Pty Ltd will serve as the independent registered public accounting firm for the fiscal year ending June 30, 2026.

Key Dates

Recommendation

This 8-K reports routine corporate governance matters (director elections, auditor ratification) that are generally expected. It does not contain information that would fundamentally alter the investment thesis for Incannex Healthcare Inc., thus a 'hold' recommendation is appropriate as it maintains the status quo.

Keywords

Incannex Healthcare, Annual Meeting, Stockholders, Director Election, Auditor Ratification, Corporate Governance, SEC Filing, Nasdaq, IXHL